Clinical Trials

“Never seen anything like this”

– Lead Researcher at national stroke center

REQUIREMENTS

PAID RESEARCH OPPORTUNITY FOR STROKE PATIENTS

  • Age 21-80
  • Unilateral stroke
  • Gait Deficit but can walk independently with or without a cane
  • Stroke occurred more than 6 months ago

Participation is completely voluntary and non-invasive.

DESIGN AND PILOT STUDY

The iStride™ Device (originally titled GEMS) can be used overground walking and in one’s own home, thus enabling long-term training. This does not require any external power and is completely passive; all necessary forces are redirected from the natural forces present during walking.

“As a physical therapist with an extensive background in neurological rehabilitation, this device is truly one of a kind. Not only does this device improve overall gait symmetry, but it also integrates a digital sensor and gait analysis package, allowing for the user, practitioner, and caregiver, to follow and analyze progress. Additionally, the iStride™device allows for both clinic and home use, helping to bridge a gap that currently exists in the rehab world. There is a big disconnect with patients and their caregivers from time of discharge to their home environment. This device has the ability to help patients continue to benefit from rehabilitation, independently, in their own home.”

Lauren Rashford, DPT

Physical Therapist, Director of Clinical Operations at Moterum

EFFECTS

The iStride™ device produces a similar effect of moving the leg to that of a split belt treadmill , to improve a patient’s gait asymmetry. However, the iStride™ device is used walking over ground, allowing the patient to use the device both in clinic and at home. By using overground, the learns to walk again as they will walk after using the device, addressing one issue that arises with treadmill therapies. Additionally, the iStride™ device has specifically improved patients step length symmetry, double limb support phase symmetry, and gait velocity, making it the only treatment we are aware of which has achieved this.

Join our Trial

Clinical Trials Signup

  • Must be 21-80 years old.